Rocha, Flávia Gomes de Góes; Chaves, Karen Cristina Barbosa; Chammas, Roger; Peron, Jean Pierre Schatzmann 
; Rizzo, Luiz Vicente; Schor, Nestor Schor; Bellini, · Maria Helena
Source: Cancer Immunology Immunotherapy. Unidade: FM
Subjects: CAMUNDONGOS, MODELOS ANIMAIS, GENES (TERAPIA), METÁSTASE NEOPLÁSICA (PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Flávia Gomes de Góes et al. Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice. Cancer Immunology Immunotherapy, v. 59, n. 9, p. 1357-1365, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00262-010-0865-6. Acesso em: 08 nov. 2024.APA
Rocha, F. G. de G., Chaves, K. C. B., Chammas, R., Peron, J. P. S., Rizzo, L. V., Schor, N. S., & Bellini, · M. H. (2010). Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice. Cancer Immunology Immunotherapy, 59( 9), 1357-1365. doi:10.1007/s00262-010-0865-6NLM
Rocha FG de G, Chaves KCB, Chammas R, Peron JPS, Rizzo LV, Schor NS, Bellini · MH. Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice [Internet]. Cancer Immunology Immunotherapy. 2010 ; 59( 9): 1357-1365.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s00262-010-0865-6Vancouver
Rocha FG de G, Chaves KCB, Chammas R, Peron JPS, Rizzo LV, Schor NS, Bellini · MH. Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice [Internet]. Cancer Immunology Immunotherapy. 2010 ; 59( 9): 1357-1365.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s00262-010-0865-6
